Laboratorios Farmaceúticos Rovi SA (LABFF)
65.86
0.00 (0.00%)
USD |
OTCM |
Mar 05, 16:00
Laboratorios Farmaceúticos Rovi EPS Diluted (Quarterly) : 0.9711 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Grifols SA | 0.168 |
| Pharma Mar SA | 3.978 |
| Oryzon Genomics SA | -0.0202 |
| Almirall SA | -- |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 49.65M |
| Revenue (Quarterly) | 254.23M |
| Total Expenses (Quarterly) | 204.55M |
| Enterprise Value | 3.410B |
| Gross Profit Margin (Quarterly) | 59.87% |
| Profit Margin (Quarterly) | 19.53% |
| Earnings Yield | 4.78% |
| Operating Earnings Yield | 5.89% |
| Normalized Earnings Yield | 4.782 |